(UBU7) UBS (Irl) - MSCI World - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE00B7KQ7B66

UBU7: Global, Large-Cap, Equities, Blend

The UBS (Irl) ETF plc - MSCI World UCITS ETF (USD) A-dis EUR is an exchange-traded fund that tracks the Morningstar Global TME NR USD index, providing investors with broad exposure to the global equity market. As a Global Large-Cap Blend Equity ETF, it invests in a diverse portfolio of large-cap stocks from around the world, aiming to replicate the performance of the underlying index.

With its domicile in Germany and listing on XETRA, the ETF offers a convenient investment vehicle for European investors seeking to gain exposure to the global equity market. The fund is managed by UBS, a reputable asset management firm with a strong track record in ETF management.

Analyzing the ETFs technical data, we observe that the current price is 82.82 EUR, with a 20-day simple moving average (SMA) of 79.10 EUR, indicating a recent upward trend. The 50-day SMA is 82.55 EUR, closely aligned with the current price, while the 200-day SMA is 85.42 EUR, suggesting a potential resistance level. The average true range (ATR) is 2.02 EUR, or 2.43% of the current price, indicating moderate volatility.

From a fundamental perspective, the ETF has assets under management (AUM) of 318.76 million EUR, indicating a relatively modest size compared to other ETFs in the Global Large-Cap Blend Equity category. However, this size can be beneficial for investors as it allows for more agile management and potentially lower trading costs.

Forecasting the ETFs future performance, we can analyze the technical and fundamental data. Given the recent upward trend and the ETFs proximity to its 52-week high of 93.59 EUR, we can expect the price to continue to move upwards, potentially testing the 200-day SMA as resistance. However, the ATR indicates moderate volatility, and any significant news or market events could impact the price. Based on the SMA20 and SMA50, a bullish crossover is evident, suggesting a potential buy signal. Therefore, we forecast a potential price target of 90 EUR in the short term, with a stop-loss around 78 EUR to limit potential losses.

Additional Sources for UBU7 ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

UBU7 ETF Overview

Market Cap in USD 372m
Category Global Large-Cap Blend Equity
TER 0.10%
IPO / Inception 2012-04-11

UBU7 ETF Ratings

Growth Rating 67.9
Fundamental -
Dividend Rating 58.1
Rel. Strength -8.96
Analysts -
Fair Price Momentum 97.95 EUR
Fair Price DCF -

UBU7 Dividends

Dividend Yield 12m 1.49%
Yield on Cost 5y 2.82%
Annual Growth 5y 8.21%
Payout Consistency 95.1%
Payout Ratio %

UBU7 Growth Ratios

Growth Correlation 3m 64.3%
Growth Correlation 12m 31.7%
Growth Correlation 5y 89.9%
CAGR 5y 13.43%
CAGR/Max DD 5y 0.62
Sharpe Ratio 12m 0.70
Alpha -5.99
Beta 0.757
Volatility 10.09%
Current Volume 1.2k
Average Volume 20d 2.9k
What is the price of UBU7 shares?
As of June 27, 2025, the stock is trading at EUR 85.63 with a total of 1,182 shares traded.
Over the past week, the price has changed by +0.71%, over one month by -0.09%, over three months by -0.84% and over the past year by +5.03%.
Is UBS (Irl) - MSCI World a good stock to buy?
Yes. Based on ValueRay´s Analyses, UBS (Irl) - MSCI World (XETRA:UBU7) is currently (June 2025) a good stock to buy. It has a ValueRay Growth Rating of 67.88 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of UBU7 is around 97.95 EUR . This means that UBU7 is currently undervalued and has a potential upside of +14.39% (Margin of Safety).
Is UBU7 a buy, sell or hold?
UBS (Irl) - MSCI World has no consensus analysts rating.
What are the forecasts for UBU7 share price target?
According to our own proprietary Forecast Model, UBU7 UBS (Irl) - MSCI World will be worth about 111.8 in June 2026. The stock is currently trading at 85.63. This means that the stock has a potential upside of +30.5%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 111.8 30.5%